Compounds and their uses for alleviating menopause-associated symptoms
AssigneeEstetra Srl
InventorsMelanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
Life of this patent
Estimating the term…
Abstract
The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
Claims20
A method of alleviating psychological menopause-associated symptoms in a subject in need thereof, wherein the psychological menopause-associated symptoms comprise one or more selected from depression, irritability, anxiety, and nervous tension, wherein said method comprises administering to the subject an estetrol component at a daily amount equivalent to from about 15 mg to about 25 mg of estetrol.
Dependencies are inferred from the claim text.